Kristin S. Hill, Ph.D. - Publications

Affiliations: 
2011 University of Texas Medical Branch, Galveston, TX 
Area:
Cell Biology, Oncology

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Hill KS, Roberts ER, Wang X, Marin E, Park TD, Son S, Ren Y, Fang B, Yoder S, Kim S, Wan L, Sarnaik AA, Koomen JM, Messina JL, Teer JK, et al. PTPN11 plays oncogenic roles and is a therapeutic target for BRAF wild-type melanomas. Molecular Cancer Research : McR. PMID 30355677 DOI: 10.1158/1541-7786.Mcr-18-0777  0.313
2014 Tao X, Hill KS, Gaziova I, Sastry SK, Qui S, Szaniszlo P, Fennewald S, Resto VA, Elferink LA. Silencing Met receptor tyrosine kinase signaling decreased oral tumor growth and increased survival of nude mice. Oral Oncology. 50: 104-12. PMID 24268630 DOI: 10.1016/J.Oraloncology.2013.10.014  0.665
2014 Hill KS, Erdogan E, Khoor A, Walsh MP, Leitges M, Murray NR, Fields AP. Protein kinase Cα suppresses Kras-mediated lung tumor formation through activation of a p38 MAPK-TGFβ signaling axis. Oncogene. 33: 2134-44. PMID 23604119 DOI: 10.1038/Onc.2013.147  0.304
2013 Wang Y, Hill KS, Fields AP. PKCι maintains a tumor-initiating cell phenotype that is required for ovarian tumorigenesis. Molecular Cancer Research : McR. 11: 1624-35. PMID 24174471 DOI: 10.1158/1541-7786.Mcr-13-0371-T  0.373
2013 Garnett J, Chumbalkar V, Vaillant B, Gururaj AE, Hill KS, Latha K, Yao J, Priebe W, Colman H, Elferink LA, Bogler O. Regulation of HGF expression by ΔEGFR-mediated c-Met activation in glioblastoma cells. Neoplasia (New York, N.Y.). 15: 73-84. PMID 23359207 DOI: 10.1593/Neo.121536  0.641
2012 Hill KS, Gaziova I, Harrigal L, Guerra YA, Qiu S, Sastry SK, Arumugam T, Logsdon CD, Elferink LA. Met receptor tyrosine kinase signaling induces secretion of the angiogenic chemokine interleukin-8/CXCL8 in pancreatic cancer. Plos One. 7: e40420. PMID 22815748 DOI: 10.1371/Journal.Pone.0040420  0.71
2010 Hill KS, Lorinczi M, Elferink LA. Altered down regulation of the receptor tyrosine kinase met in pancreatic adenocarcinoma cells. Journal of Experimental Therapeutics & Oncology. 8: 297-312. PMID 21222362  0.721
2009 Gao X, Lorinczi M, Hill KS, Brooks NC, Dokainish H, Ireton K, Elferink LA. Met receptor tyrosine kinase degradation is altered in response to the leucine-rich repeat of the Listeria invasion protein internalin B. The Journal of Biological Chemistry. 284: 774-83. PMID 18990695 DOI: 10.1074/Jbc.M805989200  0.641
2008 Li N, Hill KS, Elferink LA. Analysis of receptor tyrosine kinase internalization using flow cytometry. Methods in Molecular Biology (Clifton, N.J.). 457: 305-17. PMID 19066037 DOI: 10.1007/978-1-59745-261-8_23  0.689
2008 Hill KS, Brooks NC, Lorinczi M, O'Connor K, Elferink LA. DYSREGULATED MET DOWN REGULATION IN PANCREATIC CANCER Pancreas. 37: 475. DOI: 10.1097/01.Mpa.0000335477.91925.F1  0.645
2006 Hill K, Cruz-Monserrate Z, O'Connor K, Elferink LA. DYSREGULATED cMET DOWN REGULATION IN PANCREATIC ADENOCARCINOMA CELLS Pancreas. 33: 469. DOI: 10.1097/00006676-200611000-00111  0.661
Show low-probability matches.